2021
DOI: 10.1155/2021/5561129
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia

Abstract: Diabetes mellitus termed as metabolic disorder is a collection of interlinked diseases and mainly body’s inability to manage glucose level which leads to cardiovascular diseases, renal failure, neurological disorders, and many others. The drugs contemporarily used for diabetes have many inevitable side effects, and many of them have become less responsive to this multifactorial disorder. Momordica charantia commonly known as bitter gourd has many bioactive compounds with antidiabetic properties. The current st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 56 publications
(55 reference statements)
0
26
0
1
Order By: Relevance
“…In addition to the presence of natural compounds, Momordica charantia can synthesize peptides that can bind to the insulin receptor, lowering blood glucose levels. These peptides may help reduce the need for insulin and limit the side effects of antidiabetic drugs [ 59 ].…”
Section: Plants Involved In Diabetes Mellitus Managementmentioning
confidence: 99%
See 3 more Smart Citations
“…In addition to the presence of natural compounds, Momordica charantia can synthesize peptides that can bind to the insulin receptor, lowering blood glucose levels. These peptides may help reduce the need for insulin and limit the side effects of antidiabetic drugs [ 59 ].…”
Section: Plants Involved In Diabetes Mellitus Managementmentioning
confidence: 99%
“…The hypoglycaemic activity of insulin-like peptides from Momordica charantia was determined using a molecular docking approach. The study investigated the activity of several peptides such as LIVA, EKAI, EALF, DFGAS and EPGGGG on four target proteins, namely the experimentally determined structures of IR, SGLT1, dipeptidyl peptidase-IV, and the predicted 3D structure of GLUT2 ( Table 1 ) [ 59 ]. In the Sadiq et al study, bioactive components in Eryngium caeruleum were discovered using GC-MS and HPLC-DAD investigations.…”
Section: Molecular Docking and Molecular Dynamics Predicted Anti-diabetic Activitymentioning
confidence: 99%
See 2 more Smart Citations
“…The crystal structure of CCR7 is available in the protein data bank [14] and could serve as an excellent starting receptor to be used in computational drug design methods. In advanced drug development strategies, structural-based drug design is an effective way to accelerate lead molecule identification [15][16][17]. Considering this, in this study, we performed structurebased virtual screening of phytochemicals collected from Saudi medicinal plants [18].…”
Section: Introductionmentioning
confidence: 99%